S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q2 2026

RTW Investments

Period: Q2 2026 · Filed: 2026-08-14
View on SEC EDGAR
AUM
$11.71B
Total portfolio value
Positions
84
Reported securities
Top Holding
MDGL
9.1% $1.07B
QoQ Changes
+8 / -8
new · exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings — not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares — not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with ≥$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2026-08-14) shown is the underlying stock price movement — not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MDGLMADRIGAL PHARMACEUTICALS INC$1.07B9.14%$536.95$507.56-5.5%
9.1%
ARGXARGENX SE$658.2M5.62%$927.77$851.29-8.2%
5.6%
PTCTPTC THERAPEUTICS INC$631.9M5.39%$81.57$71.70-12.1%
5.4%
PTGXPROTAGONIST THERAPEUTICS INC$620.4M5.30%$122.58$155.10+26.5%
5.3%
CGONCG ONCOLOGY INC$605.0M5.16%$71.05$75.03+5.6%
5.2%
INSMINSMED INC$516.4M4.41%$106.62$123.74+16.1%
4.4%
TNGXTANGO THERAPEUTICS INC$434.5M3.71%$31.26$25.60-18.1%
3.7%
SYRESPYRE THERAPEUTICS INC$377.5M3.22%$88.78$103.63+16.7%
3.2%
CELCCELCUITY INC$345.8M2.95%$104.62$92.00-12.1%
3.0%
ERASERASCA INC$328.8M2.81%$18.32$18.38+0.3%
2.8%
RDNTRADNET INC$298.9M2.55%$61.67$76.35+23.8%
2.5%
ORKAORUKA THERAPEUTICS INC$298.7M2.55%$95.17$111.04+16.7%
2.5%
NTRANATERA INC$271.4M2.32%$271.45$309.93+14.2%
2.3%
RAREULTRAGENYX PHARMACEUTICAL IN$260.3M2.22%$33.39$26.49-20.7%
2.2%
IRTCIRHYTHM HOLDINGS INC$259.6M2.22%$118.95$126.44+6.3%
2.2%
CYTKCYTOKINETICS INC$243.8M2.08%$85.19$74.13-13.0%
2.1%
KLRAKAILERA THERAPEUTICS INC$237.4M2.03%$22.03$17.94-18.6%
2.0%
ESTAESTABLISHMENT LABS HLDGS INC$227.9M1.95%$85.81$79.47-7.4%
1.9%
GHGUARDANT HEALTH INC$222.2M1.90%$150.03$157.21+4.8%
1.9%
NBIXNEUROCRINE BIOSCIENCES INC$213.7M1.82%$168.54$152.72-9.4%
1.8%
TARSTARSUS PHARMACEUTICALS INC$211.3M1.80%$62.94$69.20+9.9%
1.8%
STOKSTOKE THERAPEUTICS INC$184.0M1.57%$32.72$31.27-4.4%
1.6%
QUREUNIQURE NV$181.6M1.55%$46.06$48.62+5.6%
1.6%
ACADACADIA PHARMACEUTICALS INC$180.8M1.54%$25.30$28.24+11.6%
1.5%
RGENREPLIGEN CORP$169.3M1.45%$136.44$166.83+22.3%
1.4%
URGNUROGEN PHARMA LTD$167.2M1.43%$36.80$48.22+31.0%
1.4%
GHRSGH RESEARCH PLC$159.5M1.36%$26.88$29.49+9.7%
1.4%
IMCRIMMUNOCORE HLDGS PLC$154.6M1.32%$31.75$34.21+7.8%
1.3%
CMPSCOMPASS PATHWAYS PLC$151.4M1.29%$14.15$13.45-5.0%
1.3%
IMTXIMMATICS N.V$131.1M1.12%$10.13$9.44-6.8%
1.1%

Quarter-on-Quarter Activity

Q2 2026 vs. Q1 2026

New Positions (8)

TickerIssuerNotionalSince Filing
KLRAKAILERA THERAPEUTICS INC$237.4M-18.6%
GPCRSTRUCTURE THERAPEUTICS INC$86.3M
AXGNAXOGEN INC$46.7M
DHRDANAHER CORP DEL$43.8M
SLDBSOLID BIOSCIENCES INC$38.9M
IDYAIDEAYA BIOSCIENCES INC$13.8M
ALLOALLOGENE THERAPEUTICS INC$6.8M
MAZEMAZE THERAPEUTICS INC$6.3M

Exited Positions (8)

TickerIssuerNotional
APGEAPOGEE THERAPEUTICS INC$234.2M
APLSAPELLIS PHARMACEUTICALS INC$148.3M
ISRGINTUITIVE SURGICAL INC$101.4M
CNTACENTESSA PHARMACEUTICALS PLC$81.6M
CRNXCRINETICS PHARMACEUTICALS IN$52.7M
WAYWAYSTAR HLDG CORP$39.3M
ARWRARROWHEAD PHARMACEUTICALS IN$36.7M
SYKSTRYKER CORPORATION$32.9M

Increased (8)

TickerIssuerNotionalShares ΔSince Filing
RAREULTRAGENYX PHARMACEUTICAL IN$183.9M+113.7%-20.7%
TENXTENAX THERAPEUTICS INC$4.2M+88.1%
LRMRLARIMAR THERAPEUTICS INC$1.1M+71.1%
ORKAORUKA THERAPEUTICS INC$197.8M+52.5%+16.7%
QUREUNIQURE NV$139.3M+52.4%+5.6%
CGEMCULLINAN THERAPEUTICS INC$18.8M+38.6%
DFTXDEFINIUM THERAPEUTICS INC$13.2M+33.3%
IRTCIRHYTHM HOLDINGS INC$62.7M+30.8%+6.3%

Trimmed (8)

TickerIssuerNotionalShares ΔSince Filing
AVTXAVALO THERAPEUTICS INC$-9.6M-79.6%
HNGEHINGE HEALTH INC$-32.9M-74.1%
COGTCOGENT BIOSCIENCES INC$-120.8M-57.7%
XGNEXAGEN INC$-0.3M-50.7%
HTFLHEARTFLOW INC$-3.4M-40.4%
BBNXBETA BIONICS INC$3.5M-25.0%
NTRANATERA INC$21.5M-20.0%+14.2%
TSHATAYSHA GENE THERAPIES INC$31.2M-0.9%
Back to Hedge Funds